Clear Creek Financial Management’s Recursion Pharmaceuticals RXRX Stock Holding History

Clear Creek Financial Management's RXRX Position: Q2 2026 in Review

Clear Creek Financial Management increased its Recursion Pharmaceuticals (RXRX) stake by 3.1% in Q2 2026, buying an estimated $4.39K and bringing the position to 44,271 shares worth $162K. The position accounts for 0.01% of the portfolio, ranked #626.

Clear Creek Financial Management first reported a position in RXRX in Q3 2024 and has held it in 8 quarters since. The position peaked at $599K in Q3 2025. 170 funds tracked by Wall St. Rank hold RXRX as of Q2 2026.

• Clear Creek Financial Management held 44,271 shares of Recursion Pharmaceuticals worth $162K as of Q2 2026.
• Clear Creek Financial Management bought 1,318 Recursion Pharmaceuticals shares in Q2 2026, an estimated $4.39K.
• Recursion Pharmaceuticals made up 0.01% of Clear Creek Financial Management's portfolio in Q2 2026, its #626 holding.
• Clear Creek Financial Management first reported a position in Recursion Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
• Clear Creek Financial Management's Recursion Pharmaceuticals position peaked at $599K in Q3 2025.
• 170 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q2 2026.

Based on Clear Creek Financial Management's 13F filing for Q2 2026, filed 28 Jul 2026.